Answers are grounded in this paper and cite their sources.
Research reveals strong antimicrobial activity of bioactive compounds in Streptomyces coelicolor, indicating its potential against antibiotic-resistant strains.
This research examines the antimicrobial efficacy of Actinomycetes procured from marine sediment specimens, with a particular emphasis on the Streptomyces coelicolor strain KR23. The phylogenetic assessment, predicated on 16S rRNA gene sequencing, indicated that the isolated strain exhibits a close phylogenetic relationship with S. coelicolor, a species renowned for its extensive biosynthetic and metabolic functionalities. The extraction of bioactive compounds was conducted utilizing ethyl acetate and antimicrobial evaluations revealed considerable activity against a variety of bacterial pathogens including Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pyogenes. The analysis via Gas Chromatography-Mass Spectrometry (GC-MS) discerned crucial bioactive compounds such as 2-phenylacetamide, succinic acid, plicamycin, uric acid, Gentamicin and l-tyrosine butyl ester. These compounds, which demonstrate a spectrum of action mechanisms, underscore the potential of S. coelicolor strain KR23 as a significant resource for the innovation of novel antimicrobial agents. Additional investigations are warranted to elucidate the synergistic interactions of these compounds and their implications in addressing antibiotic-resistant bacterial strains.
No takes yet. Share an insight, caveat, or question.
Kiruthiga et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: